
Conscience Issue Tracker - July 8 2024Issues in this in this edition: C-Path and Centogene partner to advance drug development for lysosomal diseases Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria BenevolentAI and AstraZeneca collaboration success continues as novel target progressed Collaboration leads to creation of potent therapy candidate for fatal prion diseases DiaGen Ai Inc. Announces Research Collaboration with the Structural Genomics Consortium at UNC Chapel Hill
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
